Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Bufalin, a Traditional Oriental Medicine, Induces Apoptosis in Human Cancer Cells

  • Takai, Noriyuki (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine) ;
  • Kira, Naoko (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine) ;
  • Ishii, Terukazu (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine) ;
  • Yoshida, Toshie (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine) ;
  • Nishida, Masakazu (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine) ;
  • Nishida, Yoshihiro (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine) ;
  • Nasu, Kaei (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine) ;
  • Narahara, Hisashi (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine)
  • Published : 2012.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Bufalin is a traditional oriental medicines which induces apoptosis in some lines of human tumor cells. It constitutes the major digoxin-like immunoreactive component of Chan Su, obtained from the skin and parotid venom glands of toads. Bufalin is cardioactive C-24 steroids that exhibits a variety of biological activities, such as cardiotonic, anaesthetic, blood pressure stimulatory, respiratory and antineoplastic effects. In terms of its anti-tumor activity, bufalin has been demonstrated to inhibit the growth of tumors, such as endometrial and ovarian cancers. This commentary introduces biologic and therapeutic effects of bufalin in treating some cancers. The compound is able to mediate inhibition of cell growth, cell cycle arrest, apoptosis, and expression of genes related to the malignant phenotype in human cancer cells.

Keywords

References

  1. Chueh FS, Chen YY, Huang AC, et al (2011). Bufalininhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways. Environ Toxicol, in press.
  2. Dong Y, Yin S, Li J, et al (2011). Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway. Apoptosis, 16, 394-403. https://doi.org/10.1007/s10495-011-0573-5
  3. Han KQ, Huang G, Gu W, et al (2007). Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World J Gastroenterol, 13, 3374-9. https://doi.org/10.3748/wjg.v13.i24.3374
  4. Hong SH, Choi YH (2012). Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells. Oncol Rep, 27, 114-20.
  5. Hong Z, Chen K, Yeung HW (1992). Simultaneous determination of bufadienolides in the traditional Chinese medicine preparation, Liu Shen Wan, by liquid chromatography. J Pharm Pharmacol, 44, 1023-6. https://doi.org/10.1111/j.2042-7158.1992.tb07086.x
  6. Jiang Y, Zhang Y, Luan J, et al (2010). Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. Cytotechnology, 62, 573-83. https://doi.org/10.1007/s10616-010-9310-0
  7. Jing Y, Watabe M, Hashimoto S, et al (1994a). Cell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cells. Anticancer Res, 14, 1193-8.
  8. Jing Y, Ohizumi H, Kawazoe N, et al (1994b). Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells. Jpn J Cancer Res, 85, 645-51. https://doi.org/10.1111/j.1349-7006.1994.tb02408.x
  9. Kawazoe N, Watabe M, Masuda Y, et al (1999). Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene, 18, 2413-21. https://doi.org/10.1038/sj.onc.1202555
  10. Krenn L, Kopp B (1998). Bufadienolides from animal and plant sources. Phytochemistry, 48, 1-29. https://doi.org/10.1016/S0031-9422(97)00426-3
  11. Li D, Qu X, Hou K, et al (2009). PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Anticancer Drugs, 20, 59-64. https://doi.org/10.1097/CAD.0b013e3283160fd6
  12. Masuda Y, Kawazoe N, Nakajo S, et al (1995). Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res, 19, 549-56. https://doi.org/10.1016/0145-2126(95)00031-I
  13. Meng Z, Yang P, Shen Y, et al (2009). Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer, 115, 5309-18. https://doi.org/10.1002/cncr.24602
  14. Morishita S, Shoji M, Oguni Y (1992). Pharmacological actions of 'Kyusin', a drug containing toad venom: cardiotonic and arrhythmogenic effects. Am J Chin Med, 20, 245-6. https://doi.org/10.1142/S0192415X92000254
  15. Numazawa S, Shinoki M, Ito H, et al (1994). Involvement of Na+,K+-ATPase inhibition in K562 cell differentiation induced by bufalin. J Cell Physiol, 160, 113-20. https://doi.org/10.1002/jcp.1041600114
  16. Panesar NS (1992). Bufalin and unidentified substance(s) in traditional Chinese medicine cross-react in commercial digoxin assay. Clin Chem, 38, 2155-6.
  17. Song H, Guo T, Bi K, et al (2000). Determination of resibufogenin and cinobufagin in heart-protecting musk pill by HPLC. Biomed Chromatogr, 14, 130-2. https://doi.org/10.1002/(SICI)1099-0801(200004)14:2<130::AID-BMC929>3.0.CO;2-1
  18. Takai N, Ueda T, Nishida M, et al (2008). Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med, 21, 637-43.
  19. Watabe M, Ito K, Masuda Y, et al. (1998). Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene, 16, 779-87. https://doi.org/10.1038/sj.onc.1201592
  20. Xie CM, Chan WY, Yu S, et al (2011). Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation. Free Radical Biol Med, 51, 1365-75. https://doi.org/10.1016/j.freeradbiomed.2011.06.016
  21. Yeh J-Y, Huang WJ, Kan S-F, et al (2003). Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate, 54, 112-24. https://doi.org/10.1002/pros.10172
  22. Yu CH, Kan SF, Pu HF, et al (2008). Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Sci, 99, 2467-76. https://doi.org/10.1111/j.1349-7006.2008.00966.x
  23. Zhang LS, Nakaya K, Yoshida T, et al (1991). Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun, 178, 686-93. https://doi.org/10.1016/0006-291X(91)90162-Z

Cited by

  1. Cytotoxicity, Apoptosis Induction and Anti-Metastatic Potential of Oroxylum indicum in Human Breast Cancer Cells vol.13, pp.6, 2012, https://doi.org/10.7314/APJCP.2012.13.6.2729
  2. AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells vol.41, pp.5, 2012, https://doi.org/10.3892/ijo.2012.1605
  3. Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions vol.42, pp.1, 2013, https://doi.org/10.3892/ijo.2012.1683
  4. Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy vol.14, pp.1, 2013, https://doi.org/10.3390/ijms14011370
  5. Bufalin induces G2/M phase arrest and triggers autophagy via the TNF, JNK, BECN-1 and ATG8 pathway in human hepatoma cells vol.43, pp.1, 2013, https://doi.org/10.3892/ijo.2013.1942
  6. Targeting Poly (ADP-Ribose) Polymerase Partially Contributes to Bufalin-Induced Cell Death in Multiple Myeloma Cells vol.8, pp.6, 2013, https://doi.org/10.1371/journal.pone.0066130
  7. Biotoxins for Cancer Therapy vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4753
  8. Blocking autophagy enhances the apoptosis effect of bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation vol.19, pp.1, 2014, https://doi.org/10.1007/s10495-013-0914-7
  9. Bufalin Alters Gene Expressions Associated DNA Damage, Cell Cycle, and Apoptosis in Human Lung Cancer NCI-H460 Cells in Vitro vol.19, pp.5, 2014, https://doi.org/10.3390/molecules19056047
  10. Bufalin Exerts Inhibitory Effects on IL-1β-Mediated Proliferation and Induces Apoptosis in Human Rheumatoid Arthritis Fibroblast-Like Synoviocytes vol.37, pp.5, 2014, https://doi.org/10.1007/s10753-014-9882-5
  11. Resibufogenin and Cinobufagin Activate Central Neurons through an Ouabain-Like Action vol.9, pp.11, 2014, https://doi.org/10.1371/journal.pone.0113272
  12. BMI-1 is important in bufalin-induced apoptosis of K562 cells vol.9, pp.4, 2014, https://doi.org/10.3892/mmr.2014.1980
  13. An in silico Appraisal to Identify High Affinity Anti-Apoptotic Synthetic Tetrapeptide Inhibitors Targeting the Mammalian Caspase 3 Enzyme vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10137
  14. Bufalin Induces Mitochondrial Pathway-Mediated Apoptosis in Lung Adenocarcinoma Cells vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10495
  15. vol.32, pp.4, 2017, https://doi.org/10.1002/tox.22325
  16. Bufadienolides of Kalanchoe species: an overview of chemical structure, biological activity and prospects for pharmacological use vol.16, pp.6, 2017, https://doi.org/10.1007/s11101-017-9525-1
  17. Bufalin Induces Apoptosis of Human Osteosarcoma U-2 OS Cells through Endoplasmic Reticulum Stress, Caspase- and Mitochondria-Dependent Signaling Pathways vol.22, pp.3, 2017, https://doi.org/10.3390/molecules22030437
  18. Blocking autophagy enhances the pro-apoptotic effect of bufalin on human gastric cancer cells through endoplasmic reticulum stress vol.6, pp.10, 2017, https://doi.org/10.1242/bio.026344
  19. Bufalin Enhances the Cytotoxity of Human Multiple Myeloma Cells H929 to AKT Inhibitor MK2206: The Role of Protein AKT Phosphorylation pp.0974-0449, 2017, https://doi.org/10.1007/s12288-017-0883-z
  20. Hyperthermia and radiation reduce the toxic side-effects of bufadienolides for cancer therapy vol.14, pp.1, 2017, https://doi.org/10.3892/ol.2017.6256
  21. Cardiac glycoside/aglycones inhibit HIV-1 gene expression by a mechanism requiring MEK1/2-ERK1/2 signaling vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-19298-x
  22. Bufalin suppresses endometriosis progression by inducing pyroptosis and apoptosis vol.237, pp.3, 2018, https://doi.org/10.1530/JOE-17-0700
  23. The Development of Toad Toxins as Potential Therapeutic Agents vol.10, pp.8, 2018, https://doi.org/10.3390/toxins10080336
  24. The sodium pump α1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway pp.1573-6822, 2019, https://doi.org/10.1007/s10565-019-09462-y